Genoskin uses donated human skin samples that are kept alive to generate first-in-human clinical data in order to derisk drug, vaccine & compound development.
We’re live at #SIDChicago26!
Come meet the Genoskin team at our booth and discover how our ex vivo human skin platforms support dermatology research.
🧪 Stop by to chat with our experts
📍 Find us at booth #102
Looking forward to connecting with you!
Heading to #SIDChicago26? So are we!
Join Genoskin at the SID 83rd Annual Meeting and explore how human ex vivo skin models are advancing dermatology research.
📍 We will welcome you to our booth: #102
🧪 Don’t miss our poster presentations! Look for posters #0662 and #1038.
Accelerating #antiaging trials using real human #skin...
@Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing.
#longevity#biotech
https://t.co/janhPnTeOn
�� Very excited to announce the preprint of our #academic article on the MANTIS® #spatialbiology platform under the title: "3-D deconvolution of human skin #immune architecture with Multiplex Annotated Tissue Imaging System (MANTIS®)".
https://t.co/knWjViz6Sq
🐰 Happy #ChineseNewYear2023 to everyone! As serendipity will have it, 2023 is the year of the rabbit and therefore provides the perfect timing to focus on #animalfree#drug and #vaccine research!
Learn more here 👇
https://t.co/CGIruXB27h
🚨 If you're in the #Boston area, come meet our CSO and #immunology expert, Dr. Nicolas Gaudenzio!
🎯 He'll be in Kendall Sq. on Feb 2, 2023 to present our bio-stabilized skin model for high-dimensional #profiling of immune response to #injectable drugs.
https://t.co/QA6tbu7F2m
🙏 A huge thank you to all our amazing customers, donors, and teams in France and in the US, for an amazing 2022!
🎄Happy holidays to all! Here's to an even better 2023!
#thankyou
🎟 We’re delighted to announce that @Evotec Toulouse and Michael Esquerré, VP Immuno-Oncology, have invited Nicolas Gaudenzio, our CSO and Research Director of the @InsermOccPy Infinity Lab, for a live #evoseminar presentation at the Curie Campus in Toulouse on January 10th!
🚨 Last chance to register for tomorrow's @LeicaMicro#MicroscopyFocus#webinar with Dr Nicolas Gaudenzio, our CSO, on an easy way to perform 10+/- color #imaging of tissue samples to assess the skin #immune landscape.
Don't miss out !
https://t.co/ADXLBFl2xE
💡Discover a unique, simple method to perform 10+/-color #imaging of #tissue samples and assess the skin #immune landscape. Join Dr. Nicolas Gaudenzio for an exciting @LeicaMicro#MicroscopyFocus webinar on Dec. 7th 2022 to learn more. Register now! https://t.co/n6ajezKRCo
🎟 Last chance to meet the Genoskin team in the US this year! Come join Eric Merle, our Chief Business Innovation Officer, in #Boston next week, during the upcoming #LipidNanoparticles Immunogenicity & Toxicity Summit.
https://t.co/es9oUqqbed
🚀 Today is #spatialbiology day at the joint annual meeting of the @sfiimmunologie! Check out the #dataanalysis session in the Athena Auditorium (level 2) from 11:45 am to 1:15 pm and learn all about our MANTIS® #multiplex imaging solution!
💡Come join Dr. Nicolas Gaudenzio, our Chief Scientific Officer, during the @crctoncopole#Workshop on Computational Analysis and #Multiomics in Oncology at the @IUCTOncopole auditorium in #Toulouse Monday, October 17. Don't miss out!
https://t.co/hvdGR23g23
🤔 Today’s #research on new #drugs is often complicated by a lack of relevant study tools.
💡 Genoskin now provides a reliable solution to help you #evaluate human primary #MastCell#response to your compound or formula.
Read more here 👇
https://t.co/Ppyn8teOFp